IRMD vs SBUX · P/E 51, rev $42.4M vs P/E 76, rev $37.18B
Iradimed Co (IRMD) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Iradimed Co (IRMD) is a medical devices company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the IRMD and SBUX stock pages for the full models.
Not investment advice.